A serological survey was performed in groups of patients with active sputum smear-positive or smearnegative pulmonary tuberculosis, healthy household contacts, and controls. Sera were tested for titers of antibodies which bound to each of five purified mycobacterial antigens by enzyme immunoassay and for competition of binding to single epitopes, using six radiolabeled monoclonal antibodies directed toward corresponding molecules. The evaluation of diagnostic specificity was based on a positive score represented by titers above the cutoff point of 2 standard deviations above the mean titer of a control group. For smear-positive samples, the best sensitivity (83%) was achieved by exclusive use of the 38-kilodalton (kDa) antigen or its corresponding monoclonal antibodies. For smear-negative samples, levels of antibodies binding to the 19-kDa antigen showed a lower sensitivity of 62% compared with the control group or 38% compared with the contact group. Titers of antibody binding to the 14-kDa antigen were raised in Mycobacterium bovis BCG-vaccinated contacts, indicating that the greatest potential of this antigen may be in the detection of infection in a population for which tuberculin testing is unreliable. The results demonstrated the differing antibody responses to each of the tested antigens and distinct associations with the stage of infection or disease.
The diagnosis of pulmonary tuberculosis depends on the culture of Mycobacterium tuberculosis from sputum samples. Acid-fast bacilli in a sputum smear permit the confident introduction of therapy (17) (although subsequent identification of nontuberculous mycobacteria may alter the drug regimen), while contributory evidence obtained from chest radiography and tuberculin testing is helpful. Smear test positivity is an indicator of infectious advanced disease; when the smear is negative, the delay of several weeks for a culture result, even when available, often means that the patient will become infectious. Therefore, a specific serological test, able to detect early disease, could speed up the start of therapy and reduce transmission of the infection.
Previous investigations into tuberculosis serology have been faced with problems of both sensitivity and specificity (3, 4) . Antigen preparations have contained moieties present in many microbial species that lead to serological crossreactivity (1, 15) . Recently, mouse monoclonal antibodies (MAbs) to specific epitopes on antigens of M. tuberculosis (2) have been used in a solid-phase antibody competition test (SACT) to measure antibody titers to these determinants in human sera (5, 6, 9) . Although the SACT was successful in identifying smear-positive tuberculosis, it was less valuable in "paucibacillary" disease (8) . If there were immunodominant epitopes on the antigens other than those defined by the MAbs, an improved rate of detection of smear-negative tuberculosis cases might be achieved by using the purified whole molecules to measure antibody levels. In this paper we have compared the antibody titers in human sera to six epitopes of mycobacterial antigens with antibody titers to the corresponding whole-antigen molecules with respect to their potential value for the diagnosis of tuberculosis. * Corresponding author.
MATERIALS AND METHODS Sera. Sera were collected from patients at the London Chest Hospital at the start of treatment for suspected tuberculosis. A total of 46 patients with sputum smear-positive pulmonary disease were included. For 13 smear-negative patients, treatment was commenced on the basis of radiographic evidence, although diagnosis was subsequently confirmed in 5 subjects by sputum culture. Sera were obtained from 18 contacts who lived in households each containing a person with smear-positive pulmonary tuberculosis. Control sera were obtained from 38 healthy residents of the United Kingdom. Mycobacterium bovis BCG vaccination status was confirmed by the presence of a visible scar.
MTSE. To prepare M. tuberculosis soluble extract (MTSE), strains H37Rv and H37Ra were grown as surface cultures on Sauton medium for 8 weeks. The medium was separated from the bacilli by centrifugation and rendered safe for use by filtration (Durapore 0.45-,um-pore-size filter). The bacilli were irradiated (2.5 megarads, 59Co) and disrupted as described previously (11) . Briefly, bacilli were suspended 1:1 (wet wt/vol) in ice-cold phosphate-buffered saline (Dulbecco A without Ca2+ or Mg2"; PBS) and placed in a bottle containing glass beads (diameter, 0.1 mm). The suspension was then agitated at 4,000 rpm for 2 min in a homogenizer (B. Braun, Melsungen AG, Melsungen, Federal Republic of Germany). The soluble extract was separated from the cell debris by centrifugation at 47,000 x g for 1 h at 4°C (SS-34 rotor; Ivan Sorvall, Inc., Norwalk, Conn. (10) . After incubation with the primary antibody for 1 h at 37°C, the plates were washed with PBST and bound antibody was detected by using a peroxidase-conjugated goat anti-mouse immunoglobulin antibody. Peroxidase activity was assayed by using tetramethylbenzidine and hydrogen peroxide substrates as described fully elsewhere (11 SACT. The radioimmunoassay technique used is fully described elsewhere (5, 6) . Briefly, polyvinyl microdilution plates (M24; Dynatech) were coated with 50 ,ul of 30-,ug/ml MTSE diluted in PBS overnight at 4°C. Plates were washed with PBS and then blocked with PBS containing 3% (wt/vol) bovine serum albumin. Human sera diluted in bovine serum albumin were incubated for 4 h at 20°C and then without washing incubated further with 125I-labeled MAb overnight at 4°C. After being washed and dried the wells were counted in a 1260 Multigamma Il counter (LKB-Wallac, Milton Keynes, United Kingdom).
Solid-phase antibody binding test (ELISA). Antibodies in human sera binding to solid-phase bound purified antigens of M. tuberculosis were developed by using peroxidase-conjugated anti-human immunoglobulin G (IgG). Microdilution plates (M129B) were coated with either 14-kDa, 19-kDa, 38-kDa, 65-kDa, or LAM antigens or with PBS for subsequent serum blank correction. The optimal coating concentration for each antigen, established individually, was 0.2 pug/ ml for the 14-and 19-kDa molecules, 0.35 ,ug/ml for the 38-kDa molecules, 1 ,ug/ml for the 65-kDa molecules, and 0.1 ptg/ml for LAM. The plates were incubated overnight at 4°C. They were then washed once with PBST, and nonspecific binding was blocked by the addition to each well of 150 pl of a solution of semiskimmed dried milk (J. Sainsbury, London; 1%, wt/vol) in PBST, followed by 1 h of incubation at 37°C. After the blocking solution was tipped off, 50-,ul portions of dilutions of human sera in the milk-PBST solution were added to plates individually coated with each of the antigens or with PBS alone. Plates were incubated for 1 h at 37°C and washed four times with PBST; 50 pil of affinity-purified goat anti-human IgG peroxidase conjugate (Bio-Rad Laboratories, Richmond, Calif.) diluted 1: 3,000 in milk-PBST was then added to each well, followed by a further incubation for 1 h at 37°C. After six washes with PBST, bound peroxidase activity was estimated as described earlier (11) and optical densities were corrected by subtracting the nonspecific binding to PBS-coated wells at corresponding serum dilutions. Results were calculated by expressing the binding of the test serum at each dilution as a percentage of the binding of a selected "standard" serum (high control).
Statistical analyses. Cutoff titers for antibodies binding to each antigen and antibodies competing with each MAb were defined as the log mean titer + 2 standard deviations (SD) of the control group. Sera with titers of ' 1 were all given a value of 1, and those with titers of >700 were given a value of 700. Correlations between responses to each pair of antigens were analyzed by using the Spearman rank correlation coefficients (r + 95% confidence intervals). Comparison of the distributions of antibody titers between two groups was by the Mann-Whitney U test, giving a P value and 95% confidence intervals for the difference in mean rank (d 
RESULTS
Definition of cutoff points between patient and control groups. The titers of IgG antibodies in human sera were determined in groups of patients with active smear-positive or smear-negative pulmonary tuberculosis, in healthy contacts, and ini healthy controls (Fig. 1) 1 .66 ± 0.92; smear-positive group, 2.10 ± 0.82). This increase was apparent through all groups with ML34 competition (controls, 1.16 ± 0.20; contacts, 1.27 ± 0.21; smear-negative group, 1.41 ± 0.32; smear-positive group, 1.79 ± 0.45). In view of the polysaccharide structure of the LAM antigen, sera were tested also for IgM antibodies. Although these were present in the majority of sera, the IgG responses presented in the figure discriminated between smear-positive patients and controls better than did IgM responses. Thus, 54% of patients had greater IgG than IgM titers, compared with only 29% in the control group (data not shown).
Correlations between antibody specificities. The antibody titers obtained from the 46 smear-positive patients were analyzed for possible correlations between responses to each pair of antigens. This analysis revealed the strongest correlation (r = 0.717 ± 0.072; P < 0.001) between titers of binding to the 14-kDa and LAM antigens. Binding to the 19-kDa antigen accompanied binding to the 38-kDa and 14-kDa antigens (r = 0.574 ± 0.099 and 0.523 ± 0.107, respectively; P < 0.01), although these correlations were less than that between the 14-kDa and LAM antigens. There was no significant correlation (r = 0.160) between titers of binding to the 19-and 65-kDa antigens.
Antibody titers in patients with smear-negative disease. The titers of antibodies which bound to each of the purified antigens in the sera of patients with smear-negative pulmonary tuberculosis are shown in Table 1 tribution of antibody titers to the 14-kDa antigen differed significantly between vaccinated and nonvaccinated contacts (P = 0.04; Mann-Whitney U test). Furthermore, comparison of the number of sera with titers of -1 with those having titers of >1 revealed a highly significant difference between the vaccinated contacts and the vaccinated controls (P = 0.006; Fisher exact test) but not between nonvaccinated contacts and controls (P = 0.523).
Discrimination of smear-positive and smear-negative patients from healthy controls and contacts. The percentage of correctly diagnosed cases of pulmonary tuberculosis when compared with either healthy controls or healthy household contacts was evaluated for three antigens (Table 2) . For smear-positive disease, binding to the 38-kDa antigen alone successfully diagnosed 83% of the cases. This figure was achieved when patients were compared with either of the control groups. However, the correct diagnosis of both smear-positive and smear-negative disease was reduced when titers of binding to the 19-and 14-kDa antigens were compared with those of healthy contacts rather than healthy controls. Nevertheless, the 19-kDa-antigen-binding test still offers the best positive score for the detection of smearnegative disease. On the other hand, 14-kDa-antigen binding antibodies can be elevated in response to infection even without clinically apparent tuberculosis.
DISCUSSION
The development and application of a SACT technique using mouse MAbs directed against specific epitopes on mycobacterial antigens advanced the potential for the serological diagnosis of smear-positive tuberculosis (5). Its principal advantage is the inherent epitope specificity of MAbs, with TB68, TB71, and TB72 restricted to tubercle bacilli (10). However, a possible loss of sensitivity could have resulted from the limited repertoire of antibodies to single epitopes. Therefore, we have analyzed the binding of antibodies in human sera to purified antigens which carry the epitopes recognized by the mouse MAbs. We wished to see if (i) the specificity previously demonstrated with the MAbs was retained with the whole molecules and (ii) greater sensitivity was achieved by the contribution of additional immunodominant epitopes.
All previous surveys using the SACT assay had compared antibody titers in patients with those in healthy controls who had not knowingly been in contact with active tuberculosis. We therefore compared the ELISA with the SACT on that basis first. However, we also considered that in population screening, particularly in areas where tuberculosis is endemic, a test should be able to discriminate between diseased and healthy people, even where the latter have been infected through contact with people with active tuberculosis. We therefore included a study group of individuals who lived in the same domiciliary unit as a person known to have smear-positive tuberculosis but who did not show any symptoms of the disease for 1 year after the blood sample was taken. Groups of patients were also compared with this group of contacts for both assays.
Studies of the 38-kDa antigen expanded the previous evidence that the TB71 and TB72 epitopes were restricted to tubercle bacilli (2, 10, 20) and immunodominant in tuberculosis (5, 6, 9) . No loss of specificity was observed by widening the test window to include the whole molecule. Indeed, the fact that the observed sensitivity of 83% for the 38-kDa antigen was almost identical to that for the combination of TB71 and TB72 (84%) suggests either that these two may represent the total of immunodominant epitopes on this antigen for humans or that the response to any other presumed epitopes is similar in specificity and magnitude to that of the TB71-and TB72-like responses. This interpretation agrees with the description of other MAb-defined epitopes on this molecule (12, 18) . Antibody titers (30% antigenbinding titer, >5) to the 38-kDa molecule were found only in smear-positive patients, not in contacts or in smear-negative patients. The absence of titers in the contact group is a particularly favorable pointer to the potential use of this antigen in a simple test for the diagnosis of smear-positive disease in areas in which the disease is endemic. The absence of antibodies in the smear-negative group indicates that antibody production to the 38-kDa antigen is a reflection of either bacterial load or certain pathological events associated with the advanced stage of the disease. Perhaps the kinetics of release of this antigen in vivo from live or dead, intra-or extracellular bacilli determine its immunogenicity.
The pattern of antibody response to the 19-kDa antigen was similar to that of the TB23 epitope, enabling discrimination of 61% of smear-positive patients relative to the control population. The observation that this figure was similar (62%) for patients with smear-negative disease may be indicative of an earlier response to this antigen than to the 38-kDa antigen, which had only 15% sensitivity in this same group of patients. Although there was no significant difference in the distributions of the antibody titers to the 19- It was reported previously that hospital workers having contact with tuberculosis patients had elevated TB68 antibody titers (6) . This was corroborated by the finding that titers to the 14-kDa antigen in the contact group were enhanced by prior BCG vaccination. Although the increase in titers of binding to the 14-kDa antigen in vaccinated contacts appears to be specific to sensitization by BCG, cross-reactivity at the T-cell level with other mycobacteria (13) might contribute to the response in areas with abundant environmental mycobacteria.
Even if the results from the contact group were used to establish the cutoff titers, a combination of the 14-and 19-kDa antigens successfully diagnosed four of the five smear-negative, culture-positive cases, whereas only one of eight culture-negative cases was correctly identified in this manner. Despite the small number of cases, these data warraflt further study of smear-negative pulmonary tuberculosis. Even if success were limited to the culture-positive group, this finding would still be a valuable aid in the decision of whether to treat a patient pending the outcome of the culture and hence reduce the spread of infection.
The lack of discrimination afforded by the 65-kDa antigen was expected and in general agreement with recent data. It is known that the 65-kDa antigen is a member of a family of stress proteins whose presence is ubiquitous among bacteria thus far examined (16, 19 ; J. Ivanyi, K. Sharp, P. S. Jackett, and G. H. Bothamley, Springer Semin. Immunopathol., in press). Therefore, individuals certainly encounter this antigen within commensal organisms, resulting in high natural antibody levels as shown in this study. Although the ML34 antibody is specific for the genus Mycobacterium, similar lipopolysaccharide structures are prevalent in other microorganisms, indicating that some epitopes may be crossreactive with other genera (14) . This fact may explain the wide range of antibody titers to this antigen in control subjects.
In conclusion, our results indicate that a raised level of antibody to the 38-kDa antigen is the potentially most useful serological test for smear-positive tuberculosis. Antibodies to the 19-and 14-kDa molecules are the most relevant specificities for the detection of smear-negative disease, although anti-14-kDa antigen responses occur also in a proportion of sensitized healthy subjects. In contrast, the excessive cross-reactivity of the 65-kDa and LAM antigens may be reduced only at the epitope level, currently as found by using the SACT and in the future perhaps by use of binding assays to prospective peptides and oligosaccharides.
